Looking back on a successful Bio International 2023 in Boston!
Intravacc recently participated in the renowned “Bio International Conference” held in Boston. The event provided an invaluable platform for us to showcase our proven and cutting-edge vaccine technologies, strengthen partnerships, and meet with old and new partners and friends. Bio International is one of the largest global gatherings of biotechnology and life sciences professionals, attracting industry leaders, scientists, policymakers, and investors from around the world.
Our team actively engaged with attendees through several planned and also spontaneous meetings. Our booth drew substantial attention from both industry experts and potential collaborators. What sets Intravacc apart is our 100+ years of experience in the field and our joy of working in vaccine development.
In addition to showcasing our capabilities as a CDMO and our unique vaccine candidate pipeline, Intravacc had the privilege to participate in a trade mission organized by the Dutch government, in collaboration with Bio International. The trade mission, led by Dutch Minister Ernst Kuipers, aimed to promote Dutch expertise in the life sciences sector and foster international collaborations. Our CEO Jan Groen was honored to be a part of this esteemed delegation, representing our organization’s dedication to innovation and global engagement. During the trade mission, Intravacc had the privilege of participating in high-level meetings, networking events, and discussions that provided a unique opportunity to showcase our expertise and services for vaccine development.
Moving forward, we are energized by the momentum gained at Bio International and excited about the promising prospects that lie ahead. We are looking forward to continue to shape the future of global healthcare together with you. We also look forward to seeing you soon, perhaps at “World Vaccine Congress | Europe” from 16 until 19 October in Barcelona. Our Business Development Team will be happy to see you at booth #63 and also, Dinja Oosterhoff, PhD, Intravacc’s Vice President R&D, will give a lecture on Thursday 19 October 10:15 about “Vaccine development using Outer Membrane Vesicle platform technology”.
Click here for more information about World Vaccine Congress | Europe 2023 in Barcelona.